🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This will be a randomized, double-blind, single-dose, three-period balanced...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-11-08
Trial ID
NCT01725685
Treatments Being Tested
This is a randomized, placebo-controlled, 2-period crossover, escalating re...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-02-09
Trial ID
NCT02991859
This study will evaluate the pharmacokinetics of FF, UMEC and VI administer...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-07-15
Trial ID
NCT01894386
Treatments Being Tested
The purpose of this study is to evaluate the pharmacokinetic interaction wh...
Status
Completed
Location
Life Science Services SGS Belgium NV
Start Date
2014-05
Trial ID
NCT02287272
Treatments Being Tested
A randomised, placebo controlled thorough QTc study to evaluate the effect ...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-06-23
Trial ID
NCT01209026
This is a phase IIIa, randomised, double-blind, double-dummy, parallel grou...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-01-23
Trial ID
NCT02345161
The purpose of this study is to demonstrate dose proportionality of flutica...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-10-04
Trial ID
NCT01213849
The combination of FF, an ICS and VI, an orally inhaled LABA has been devel...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-07-09
Trial ID
NCT02446418
Treatments Being Tested